Institutional investors hold a majority ownership of ENDP through the 86.72% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Other industry. Last, during the quarter ended December 2017, these large investors purchased a net $4.1 million shares.
Other institutional | 52.29% |
Mutual fund holders | 34.42% |
Individual stakeholders | 0.82% |